赛托斯波B通过激活Nur77-血栓模块素通路来改善败血症中的高凝血能力
Xin Lu1, Linlin Chen1, Ye Tu2
1Department of Critical Care Medicine, School of Anesthesiology, Naval Medical University, Shanghai, China.
Journal of thrombosis and haemostasis : JTH
|November 2, 2025
概括
赛托斯波-B (Csn-B) 通过在血管内皮细胞中调高Nur77和血栓模块素 (TM) 来改善败血症诱导的凝血病. 这种治疗减轻了器官损伤和高凝血能力,提高了败血症患者的生存率.
科学领域:
- 生物医学研究的研究.
- 血管生物学 血管生物学
- 败血症的研究研究.
背景情况:
- 败血症诱导的凝血病 (SIC) 与高死亡率有关.
- 血栓模块素 (TM) 对于通过活性蛋白C (APC) 进行抗凝血至关重要.
- Nur77的过度表达在内皮细胞中调节了TM.
研究的目的:
- 通过调节Nur77.7,研究cytosporone-B (Csn-B) 是否可以改善SIC的情况.
- 探索Nur77-TM通路在Csn-B对凝血病的影响中的作用.
主要方法:
- 建立了一个小鼠SIC模型,使用阴绑定和穿孔 (CLP).
- 在CLP后评估凝血指标和器官损伤 (肝脏,肺,脏).
- 评估了Csn-B对内皮细胞,小鼠存活率,微血栓和凝血/补充系统的影响.
主要成果:
- 败血症对血管内皮细胞中的Nur77进行上调;Nur77的淘汰会使败血症的结果恶化.
- 通过激活Nur77-TM通路,Csn-B减弱了前凝剂反应.
- Csn-B抑制了凝血因子的增加,增强了TM-APC活性,恢复了纤维素分解,并减少了补体激活.
结论:
- Csn-B可以改善败血症早期的凝血病.
- 该机制涉及通过Nur77对血管内皮的上调来增加内源性TM.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
497
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
497
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Acute Kidney Injury II: Pathophysiology
869
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
869
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


